Evaluation of a fibrin sealant free of bovine-derived components in an experimental vas anastomosis study

Urologia Internationalis

Volumn 65, Issue 4, 2000, Pages 196-199

  Vankemmel, Olivier ^a   De La Taille, Alexandre ^a   Burnouf, Thierry ^b   Rigot, Jean Marc ^a   Duchene, Frank ^a   Mazeman, Etienne ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b HAEMONETICS CORPORATION   (United States)

Author keywords

Aprotinin; Bovine spongiform encephalopathy; Fibrin adhesive; Tranexamic acid

Indexed keywords

APROTININ; BIOCOL; FIBRIN GLUE; TRANEXAMIC ACID;

ANASTOMOSIS; ANIMAL EXPERIMENT; ARTICLE; BOVINE SPONGIFORM ENCEPHALOPATHY; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG SCREENING; FIBRINOLYSIS; GRANULOMA; INFECTION RISK; MALE; NONHUMAN; PRION; PRIORITY JOURNAL; RAT; TENSILE STRENGTH; VAS DEFERENS; VASOVASOSTOMY;

EID: 0033773091     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000064875     Document Type: Article

References (25)

1. Fertility rates with delayed fibrin glue: Vasovasostomy
2. Delayed vasovasostomy: Experimental study using fibrin glue
3. Fibrin glue: Scientific rationale, production methods, properties and current clinical use
4. Aprotinin in perspective
5. Natural and synthetic antifibrinolytics in adult cardiac surgery: Efficacy, effectiveness and efficiency
6. Warning: Fatal reaction to the use of fibrin glue in deep hepatic wounds. Case reports
7. Iatrogenic immunization with bovine thrombin: A mechanism for prolonged thrombin times after surgery
8. Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin
9. Overview of the transmissible spongiform encephalopathies: Prion protein disorders
10. Proposed link between transmissible spongiform encephalopathies of man and animals
11. Bovine spongiform encephalopathy and man
12. Risk of human exposure to bovine spongiform encephalopathy
13. Will bovine spongiform encephalopathy transmit to humans?
14. Foodborne illness. Bovine spongiform encephalopathy
15. More than happenstance: Creutzfeldt-Jakob disease in farmers and young adults
16. Clinical pharmacology of tranexamic acid
17. Effects of antifibrinolytic agents on the life span of fibrin sealant
18. Effects of granuloma formation at site of vasovasostomy
19. The adverse effects of sperm during vasovasostomy
20. Experimental and clinical application of fibrin glue
21. Autologous fibrin tissue adhesive: Factors influencing bonding power
22. Clinical application of inhibitors of fibrinolysis
23. Biological and physical properties of a solvent detergent treated fibrin glue
24. Safety aspects in manufacturing of plasma-derived coagulation factors concentrate
25. Viral safety of solvent-detergent treated blood products